2015 annual financial data
Aptevo Therapeutics 2015 Operating margin
Aptevo Therapeutics 2015 operating margin with verified reported values.
Direct answer
Operating margin was -181.84%.
Operating income was -61,100,000 USD and net income was -59,317,000 USD.
Operating cash flow was -48,760,000 USD.
Get free Aptevo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 33,601,000 USD
- Operating income
- -61,100,000 USD
- Net income
- -59,317,000 USD
- Operating cash flow
- -48,760,000 USD